大鼠在体单向肠灌流模型研究毛蕊异黄酮的吸收特征

周乐, 赵晓莉, 狄留庆, 陈瑶

周乐, 赵晓莉, 狄留庆, 陈瑶. 大鼠在体单向肠灌流模型研究毛蕊异黄酮的吸收特征[J]. 南京中医药大学学报, 2014, 30(2): 160-163.
引用本文: 周乐, 赵晓莉, 狄留庆, 陈瑶. 大鼠在体单向肠灌流模型研究毛蕊异黄酮的吸收特征[J]. 南京中医药大学学报, 2014, 30(2): 160-163.
ZHOULe, ZHAOXiao-li, DILiu-qing, CHENYao. Study on Absorption Characteristics of Calycosin in Single-pass Intestinal Perfusion Models in Vivo[J]. Journal of Nanjing University of traditional Chinese Medicine, 2014, 30(2): 160-163.
Citation: ZHOULe, ZHAOXiao-li, DILiu-qing, CHENYao. Study on Absorption Characteristics of Calycosin in Single-pass Intestinal Perfusion Models in Vivo[J]. Journal of Nanjing University of traditional Chinese Medicine, 2014, 30(2): 160-163.

大鼠在体单向肠灌流模型研究毛蕊异黄酮的吸收特征

Study on Absorption Characteristics of Calycosin in Single-pass Intestinal Perfusion Models in Vivo

  • 摘要: 目的 研究毛蕊异黄酮肠吸收动力学特征。方法 采用大鼠在体单向肠灌流模型,以酚红为标示物,研究毛蕊异黄酮在大鼠不同肠段的吸收特征。结果 毛蕊异黄酮在不同肠段均有吸收,且在结肠段吸收最好,不同浓度药物在结肠吸收中存在自身浓度抑制作用。结论 毛蕊异黄酮在小肠中吸收较好,其吸收机制可能是主动转运。
    Abstract: OBJECTIVE To study the dynamic characteristics of intestinal absorption of calycosin using signal-pass perfusion model in rats. METHODS After one-way intestinal perfusion model of rat in situ was set up,by taking phenolsulfonphthalein a maker,the absorption characteristics of different intestinal segments. RESULTS Calycosin have a good stability separately in different intestinal segments and in the colon to absorb the best. Different concentrations of drug in the colon absorption in inhibition of its concentration. CONCLUSION Calycosin is well absorbed in the small intestine and calycosin absorption may active transport.
  • [1] Kraft C, Jenett-Siems K, Siems K, et al. Antiplasmodial activity of isoflavones from Andira inermis[J]. J Ethnopharmacol, 2000, 73:131-135.
    [2] Fan Y, Wu DZ, Gong YQ, et al. Effects of calycosin on the impairment of barrier function induced by hypoxia in human umbilical vein endothelial cells[J]. European J Pharmacol, 2003, 481:33-40.
    [3] Wu XL, Wang YY, Cheng J, et al.Calcium channel blocking activity of calycosin, a major active component of Astragali Radix, on rat aorta[J]. Acta Pharmacologica Sinica, 2006, 27(8): 1007-1012.
    [4] Ma W, Nomura M, Takahashi-Nishioka T, et al. Combined effects of fangchinoline from Stephania tetrandra Radix and formononetin and calycosin from Astragalus membranaceus Radix on hyperglycemia and hypoinsulinemia in streptozotocin-diabetic mice[J].Biol Pharm Bull, 2007,30(11) 2079-2083.
    [5] Hoo RL, Wong JY, Qiao C, et al. The effective fraction isolated from Radix Astragali alleviates glucose intolerance, insulin resistance and hypertriglyceridemia in db/db diabetic mice through its anti-inflammatory activity[J]. Nutrition Metabolism,2010,7:67.
计量
  • 文章访问数:  975
  • HTML全文浏览量:  9
  • PDF下载量:  1249
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-10-24
  • 修回日期:  2014-02-09
  • 刊出日期:  2014-03-09

目录

    /

    返回文章
    返回